Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Optimal Contemporary Management of Hypertrophic Cardiomyopathy: The Importance of Early Diagnosis and Targeted Therapy

Hypertrophic cardiomyopathy (HCM) is a complex, heterogeneous disorder that affects approximately 1 in every 500 persons worldwide and about 750,000 Americans…

Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Management

Hypertrophic cardiomyopathy (HCM) affects 1 in 200-500 people and leads to hyper-contractility of the ventricles of the heart. HCM is the leading cause of sudden death in young adults, often taking an insidious clinical course…

Differentiating S1P-Based Therapeutics for the Treatment of Patients with Multiple Sclerosis

This CME program will highlight recent advances in S1P-based therapeutics for the treatment of patients with multiple sclerosis. The expert faculty, Dr. Clyde Markowitz, will first review the pharmacologic characteristics of all S1P-based therapies to aid in clinical decision making for the early intervention of patients diagnosed with multiple sclerosis (MS)…

VTE and Anticoagulation - Guideline Updates for 2024

This 0.5-hour, Whiteboard Animation Webcast is designed to review the important current guidelines for VTE and anticoagulation…

Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis

This CME program is derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2024 Course. The expert faculty, Dr. Aaron Miller, will start by analyzing the unmet needs for patients with relapsing multiple sclerosis (RMS) including tolerance and adherence to long-term treatment…

Brain Penetrant BTK Update: Reducing Neuroinflammation to Optimize Outcomes for Patients with Multiple Sclerosis

This CME program is derived from content presented at the Advanced Curriculum for Multiple Sclerosis 2024 Course. The expert faculty, Dr. Fred Lublin, will first analyze current clinical trial data for BTK therapeutics to manage patients with multiple sclerosis…

Upcoming Events

10th European Stroke Organisation Conference – ESOC 2024

May 15th – 17th, 2024

Texas Neurological Society Summer Meeting

July 19th – 20th, 2024

ESMO Congress 2024

September 13th – 17th, 2024

Alliance Industry Summit 2024

September 16th – 18th, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *